Equity Analysis

Company News

    Industry :  
    BSE Code
    ISIN Demat
    Book Value()
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    EPS(TTM)
    Face Value()
    Div & Yield %:
     
Sun Pharmaceuticals Industries consolidated net profit rises 27.98% in the September 2024 quarter
Oct 28,2024
Net profit of Sun Pharmaceuticals Industries rose 27.98% to Rs 3040.16 crore in the quarter ended September 2024 as against Rs 2375.51 crore during the previous quarter ended September 2023. Sales rose 10.51% to Rs 13264.22 crore in the quarter ended September 2024 as against Rs 12003.11 crore during the previous quarter ended September 2023.

ParticularsQuarter Ended
Sep. 2024Sep. 2023% Var.
Sales13264.2212003.11 11
OPM %29.7026.49 -
PBDT4223.793423.70 23
PBT3597.882790.88 29
NP3040.162375.51 28